Home
Charts
Search
Watchlist
Products
All IPOs
₹135 - 135
Earkart Limited
HealthcareIPOSME
₹135 - 135
We Manufacture and distribute modern hearing aids and related accessories at affordable price across India. Along with our own manufactured hearing aid, we also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad. In addition, we offer other products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged. Our mission is to make quality hearing care more accessible. We've developed a smart and easy-to-use Remote Audiometry Machine (OMNI) that allows people to get tested and fitted for hearing aids from anywhere in the world. By combining advanced technology with a strong focus on customer needs, we aim to improve hearing care across India.
Lot1,000Min Invest₹2,70,000Face Value₹10Issue Size₹49 CrFresh Issue₹45 CrOffer for Sale₹5 CrListing Price₹136CMP₹119
Timeline
25 Sept
Bidding opens
29 Sept
Bidding closes
30 Sept
Allotment
30 Sept-1 Oct
Refund & demat credit
3 Oct
Listing
Subscription
Subscription opens once dates are announced
Reports
Offer Details
Terms
Issue Size₹49 Cr0.36 Cr shares
Fresh Issue₹45 Cr
Offer for Sale₹5 Cr
Face Value₹10
Lot Size1,000 shares
ReservationNII 50% · RETAIL 50%
Application Sizes
Retail₹2,70,0001-1 lots
sNII₹2,70,000from 2 lots
bNII₹10,80,000from 8 lots
Managers & Registrar
Lead ManagerSarthi Capital Advisors Private Limited
RegistrarSkyline Financial Services Pvt
Ownership & Proceeds
Offer for Sale
Selling ShareholderShares OfferedAmt ₹ CrRohit MisraPRMTR3,34,0004.51Total3,34,0004.51
Shareholding
CategoryPre IPOPost IPOPromoter Group78.75%57.35%Public21.25%42.65%
Objects of the Issue
- Funding incremental working capital requirements of our Company
- Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities.
- General Corporate Purposes
Financials
Profit & Loss
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| RevenueCr | 6 | 29 | 32 | 43 | 54 |
| Operating ProfitCr | 0 | 2 | 4 | 10 | 8 |
| OPM% | 2.2 | 5.6 | 11.2 | 22.6 | 15.5 |
| PBTCr | 0 | 1 | 3 | 9 | 7 |
| PATCr | 0 | 1 | 3 | 7 | 5 |
| EPS | 20 | 1 | 2 | 7 | 4 |
Balance Sheet
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity CapitalCr | 0 | 0 | 0 | 10 | - |
| ReservesCr | 5 | 6 | 13 | 9 | - |
| BorrowingsCr | 0 | 1 | 4 | 5 | - |
| Total AssetsCr | 6 | 15 | 19 | 30 | - |
Cash Flow
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash FlowCr | -3 | 0 | -1 | 1 | -13 |
| Investing Cash FlowCr | -2 | 0 | -1 | -1 | -5 |
| Financing Cash FlowCr | 5 | 0 | 3 | 0 | 39 |
| Net Cash FlowCr | 0 | 1 | 1 | -1 | 21 |
Strengths & Risks
Strengths · as stated in the DRHP
- We have diversified client base ranging from government, to, clinics, retailers and doctors.
- Established and proven track record.
- Leveraging the experience of our Promoter.
- Experienced management team and a motivated Employees.
- Cordial relations with our client.
Strategies · as stated in the DRHP
- Geographical Expansion.
- Marketing Initiative.
- Continued Focus on Innovation and Technology.
Risks · as stated in the DRHP
- Our revenue from sale of products derived from government institutions accounted for 69.32%, 75.85% and 86.56% for the Fiscal 2025, Fiscal 2024 and Fiscal 2023 respectively. A failure to secure similar government contracts or orders in the future could adversely impact our business, operating results, and financial condition.
- We are subject to complex laws and governmental regulations governing our products and our business operations, compliance with these laws and regulations requires time and cost, and any adverse regulatory action may adversely affect our financial condition, cash flows and business operations.
- We face risks relating to sourcing of raw materials and components for manufacturing of our hearing aids and related devices from third parties.
- Our Manufacturing Facility is located in Noida, Uttar Pradesh. Any disruption, breakdown or shutdown of our Manufacturing may have a material adverse effect on our business, financial condition, results of operations and cash flow.
- Loss of any of our key customers or reduction in demand from our customers may materially and adversely affect our business and financial performance.
- Quality problems and product liability claims could lead to recalls or safety alerts, reputational harm, and could have an adverse effect on our business, results of operations, financial condition and cash flows.